Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine Allometric Dose in Children With Primary Visceral Leishmaniasis
NCT02431143Phase 2Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- May 2015
- Primary completion
- Apr 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of miltefosine in visceral leishmaniasis (VL), sponsored by Drugs for Neglected Diseases initiative. Started May 2015; status: completed.
02
Drugs
miltefosine
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT02431143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431143.